Funded Tech Companies

Histogenics

Histogenics, based in Waltham, has financial backing from Split Rock Partners, Sofinnova Ventures and private investors.

Company Overview

Contact Information

Company Background Information

Overview

Histogenics (NASDAQ: HSGX) is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/3/2014

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Adam Gridley

        

Chief Financial Officer

Jon Lieber

        

Chief Operating Officer

Stephen Kennedy

        

VP - Bus. Development

Donald Haut

        

VP - Engineering

Caroline Dugopolski

        

VP - Finance

Harris Shuman

        

VP - Operations

Peter Hamilton

        

Company Investors

• Split Rock Partners (Josh Baltzell)
• Sofinnova Ventures (Garheng Kong)
• Inflection Point Ventures
• Flare Capital Partners (Lee Wrubel)
• Boston Millennia Partners
• FGI Financial
• BioMed Ventures
• ProChon Holdings BV
• Altima Partners
• GIMV

Browse more funded tech companies:

Histogen | Histolix

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary